Total Payments
$147,415
2024 Payments
$122,008
Companies
5
Transactions
225
Medicare Patients
1,192
Medicare Billing
$135,526
Payment Breakdown by Category
Other$123,856 (84.0%)
Travel$14,432 (9.8%)
Consulting$4,032 (2.7%)
Food & Beverage$3,722 (2.5%)
Education$1,373 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $112,245 | 77 | 76.1% |
| Travel and Lodging | $14,432 | 47 | 9.8% |
| Honoraria | $11,611 | 11 | 7.9% |
| Consulting Fee | $4,032 | 2 | 2.7% |
| Food and Beverage | $3,722 | 77 | 2.5% |
| Education | $1,373 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $93,492 | 143 | $0 (2024) |
| Novo Nordisk Inc | $38,627 | 55 | $0 (2024) |
| Rhythm Pharmaceuticals, Inc. | $14,175 | 25 | $0 (2024) |
| Eli Lilly and Company | $1,050 | 1 | $0 (2024) |
| Foundation Medicine, Inc. | $71.03 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122,008 | 170 | Lilly USA, LLC ($93,344) |
| 2023 | $15,702 | 31 | Rhythm Pharmaceuticals, Inc. ($9,239) |
| 2022 | $9,397 | 19 | Novo Nordisk Inc ($6,569) |
| 2021 | $236.58 | 4 | Novo Nordisk Inc ($236.58) |
| 2018 | $71.03 | 1 | Foundation Medicine, Inc. ($71.03) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $101.12 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,687.50 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/22/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/22/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/22/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/22/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.75 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $880.17 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,437.50 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $122.84 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,906.25 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $84.75 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $159.50 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Travel and Lodging | Cash or cash equivalent | $25.46 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 122 | 203 | $42,581 | $14,251 |
| 2022 | 5 | 196 | 298 | $59,455 | $20,393 |
| 2021 | 11 | 414 | 652 | $123,610 | $44,333 |
| 2020 | 12 | 460 | 728 | $150,382 | $56,549 |
Total Patients
1,192
Total Services
1,881
Medicare Billing
$135,526
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 146 | $35,432 | $12,120 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,395 | $1,595 | 29.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 40 | $1,754 | $536.32 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 194 | $47,530 | $15,985 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,600 | $3,463 | 36.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 20 | 22 | $1,210 | $546.93 | 45.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 15 | 17 | $765.00 | $288.20 | 37.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 35 | 35 | $350.00 | $109.50 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 148 | $34,230 | $10,981 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 60 | 133 | $27,265 | $10,299 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 149 | $21,605 | $8,325 | 38.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 38 | $11,705 | $4,095 | 35.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 21 | $8,400 | $3,302 | 39.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $8,195 | $3,185 | 38.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 37 | 38 | $5,510 | $2,116 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 32 | $5,065 | $1,539 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $390.00 | $204.49 | 52.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 15 | $675.00 | $160.78 | 23.8% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 36 | 39 | $570.00 | $124.54 | 21.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 155 | 397 | $79,985 | $31,600 | 39.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 51 | $20,032 | $7,608 | 38.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 65 | 68 | $14,076 | $5,478 | 38.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 43 | $9,030 | $2,438 | 27.0% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 25 | 25 | $9,500 | $2,151 | 22.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 38 | $5,464 | $2,104 | 38.5% |
About Dr. Jesse Richards, D.O
Dr. Jesse Richards, D.O is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2016. The National Provider Identifier (NPI) number assigned to this provider is 1598112823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Richards, D.O has received a total of $147,415 in payments from pharmaceutical and medical device companies, with $122,008 received in 2024. These payments were reported across 225 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($112,245).
As a Medicare-enrolled provider, Richards has provided services to 1,192 Medicare beneficiaries, totaling 1,881 services with total Medicare billing of $135,526. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Obesity Medicine, Internal Medicine
- Location Tulsa, OK
- Active Since 05/17/2016
- Last Updated 11/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598112823
Products in Payments
- ZEPBOUND (Drug) $78,686
- Wegovy (Drug) $31,713
- Saxenda (Drug) $6,397
- Imcivree (Drug) $6,066
- MOUNJARO (Drug) $147.95
- FOUNDATIONONE (Device) $71.03
- Ozempic (Drug) $64.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876
Dr. Hassan Abouhouli, Md, MD
Internal Medicine — Payments: $105,547
Internal Medicine $105,547